Organigram Holdings Inc. (TSE:OGI – Get Free Report) insider Megan Mccrae sold 4,163 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total value of C$10,365.87. Following the completion of the sale, the insider owned 25,309 shares of the company’s stock, valued at C$63,019.41. This trade represents a 14.13% decrease in their ownership of the stock.
Megan Mccrae also recently made the following trade(s):
- On Thursday, October 30th, Megan Mccrae sold 2,985 shares of Organigram stock. The stock was sold at an average price of C$2.25, for a total value of C$6,716.25.
Organigram Stock Performance
Organigram stock opened at C$2.11 on Friday. The company has a debt-to-equity ratio of 3.07, a current ratio of 3.36 and a quick ratio of 2.62. Organigram Holdings Inc. has a 12 month low of C$1.22 and a 12 month high of C$2.89. The company has a fifty day moving average price of C$2.43 and a two-hundred day moving average price of C$2.11. The company has a market cap of C$282.50 million, a PE ratio of 175.83, a P/E/G ratio of 0.42 and a beta of 2.16.
Organigram Company Profile
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Articles
- Five stocks we like better than Organigram
- Investing in Travel Stocks Benefits
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Options Trading – Understanding Strike Price
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Pros And Cons Of Monthly Dividend Stocks
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
